The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Deep Dive: Regulatory Status of Popular Compounded Peptides Holt Law The Peptide Boom Is Getting Out of Hand The Atlantic FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling BPC 157 erectile dysfunction: What the evidence and user experiences actually show BPC 157: Miracle Healing Peptide or Hidden Danger?